JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arimura, A.
Right arrow Articles by Arita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arimura, A.
Right arrow Articles by Arita, H.

Vol. 298, Issue 2, 411-419, August 2001

Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751

Akinori Arimura, Kiyoshi Yasui, Junji Kishino, Fujio Asanuma, Hiroshi Hasegawa, Shinji Kakudo, Mitsuaki Ohtani and Hitoshi Arita

Discovery Research Laboratories (A.A., K.Y., J.K., F.A., S.K., M.O., H.A.) and Developmental Research Laboratories (H.H.), Shionogi & Co., Osaka, Japan

Prostaglandin (PG) D2, the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, since no DP receptor antagonist has been developed as an antiallergic drug, the role of PGD2 in the pathogenesis of allergic diseases remains uncertain. Here, we report the in vivo efficacy of our newly established DP receptor antagonist, S-5751 [((Z)-7-[(1R,2R,3S,5S)-2-(5-hydroxy benzo[b]thiophen-3-ylcarbonylamino)-10-norpinan-3-yl]hept-5- enoic acid)], using various allergic inflammation guinea pig models. In allergic rhinitis models, oral administration of S-5751 dramatically inhibited not only early nasal responses, as assessed by sneezing, mucosal plasma exudation, and nasal blockage, but also late responses such as mucosal plasma exudation and eosinophil infiltration. Even when S-5751 was administered after recovery from the early responses, these late phase responses were almost completely suppressed. In addition, S-5751 alleviated allergen-induced plasma exudation in the conjunctiva in an allergic conjunctivitis model and antigen-induced eosinophil infiltration into the lung in an asthma model. These findings provide evidence for the crucial role of PGD2 as a mediator of allergic inflammation in guinea pigs and suggest that DP receptor antagonists may be useful in the treatment of allergic diseases triggered by mast cell activation.


0022-3565/01/2982-0411$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
A. Kumar, R. Prasad, N. M. Jogge, S. Bhojraj, S. F. Emerson, and S. Prabakar
Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shiraishi, K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al.
Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation
J. Immunol., January 1, 2008; 180(1): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Schratl, J. F. Royer, E. Kostenis, T. Ulven, E. M. Sturm, M. Waldhoer, G. Hoefler, R. Schuligoi, I. Th. Lippe, B. A. Peskar, et al.
The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking
J. Immunol., October 1, 2007; 179(7): 4792 - 4799.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Sandig, J. E. Pease, and I. Sabroe
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function
J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. A. Helliwell, J. A. Keelan, K. W. Marvin, L. Adams, M. C. Chang, A. Anand, T. A. Sato, S. O'Carroll, T. Chaiworapongsa, R. J. Romero, et al.
Gestational Age-Dependent Up-Regulation of Prostaglandin D Synthase (PGDS) and Production of PGDS-Derived Antiinflammatory Prostaglandins in Human Placenta
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 597 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Spik, C. Brenuchon, V. Angeli, D. Staumont, S. Fleury, M. Capron, F. Trottein, and D. Dombrowicz
Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse
J. Immunol., March 15, 2005; 174(6): 3703 - 3708.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Shiraishi, K. Asano, T. Nakajima, T. Oguma, Y. Suzuki, T. Shiomi, K. Sayama, K. Niimi, M. Wakaki, J. Kagyo, et al.
Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. K. Mandal, Z. Zhang, R. Ray, M. S. Choi, B. Chowdhury, N. Pattabiraman, and A. B. Mukherjee
Uteroglobin Represses Allergen-induced Inflammatory Response by Blocking PGD2 Receptor-mediated Functions
J. Exp. Med., May 17, 2004; 199(10): 1317 - 1330.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
S. A. Quraishi, M. J. Davies, and T. J. Craig
Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies
J Am Osteopath Assoc, May 1, 2004; 104(5_suppl): 7S - 15S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. OGUMA, K. ASANO, T. SHIOMI, K. FUKUNAGA, Y. SUZUKI, M. NAKAMURA, H. MATSUBARA, H. K. SHELDON, K. J. HALEY, C. M. LILLY, et al.
Cyclooxygenase-2 Expression during Allergic Inflammation in Guinea-Pig Lungs
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 382 - 386.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.